Dengue Tetravalent Vaccine, Live
| Brand name | Dengvaxia |
|---|---|
| Active ingredient | Dengue Tetravalent Vaccine, Live |
| Strength | 4.5-6.0 LOG10 CCID50 CCID50: CELL CULTURE INFECTIOUS DOSE 50 |
| Dosage form | For Injection |
| Route | Subcutaneous |
| Modality | Biologic |
| FDA approval | May 2019 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.